Asia-Pacific Transfection Reagent and Equipment Market – Industry Trends and forecast period of 2021 to 2030.

Asia-Pacific transfection reagent and equipment market is expected to reach the value of USD 358,284.09 thousand by 2030, at a CAGR of 10.7% during the forecast period.

lobal Asia-Pacific Transfection Reagent and Equipment Market, By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Asia-Pacific Transfection Reagent and Equipment, Stable Asia-Pacific Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Industry Trends and Forecast to 2030

Market Definition

The transfection method is used to introduce RNA, DNA or protein products in cells to alter the phenotype and genotype of the organism. The transfection method involves the new gene transfer or transferring a gene construct such as Clustered regularly interspaced short palindromic repeats (CRISPR) for genome editing purposes. Transfection has wide applications in the field of immunotherapy, gene therapy, and cell therapy, among others. Transfection involves both non-viral and viral-mediated transfection. The chemical and physical methods can achieve non–viral transfection. The most common chemical method used for transfection is calcium phosphate transfection, and liposome transfection, among others. Viral transfection yields high transfection efficiencies, and various types of physical methods employed for transfection include microinjection, biolistic particle delivery, and electroporation, among which electroporation provides high transfection efficiency. Transfection is of two types either it can be transient or stable transfection. For short-term gene expression studies such as gene knock-out studies, small-scale production transient transfection method is preferred; however, long-term research studies and large-scale protein production stable transfection methods are widely adopted.

North America  Polyvinylpyrrolidone (PVP) Market Scope

Global Asia-Pacific Transfection Reagent and equipment market is segmented into nine notable segments such as products, stage, methods, type, types of molecule, application, end user, organism, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. 

PRODUCTS

  • INSTRUMENTS
  • REAGENT & KITS

On the basis of products, the global Asia-Pacific Transfection reagent and equipment market is segmented into instruments and reagent & kits.

STAGE

  • RESEARCH
  • PRECLINICAL
  • CLINICAL PHASES
  • COMMERCIAL

On the basis of stage, the global Asia-Pacific Transfection reagent and equipment market is segmented into research, preclinical, clinical phases and commercial.

TYPE

  • TRANSIENT ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT
  • STABLE ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT

On the basis of type, the global Asia-Pacific Transfection reagent and equipment market is segmented into transient Asia-Pacific Transfection reagent and equipment and stable Asia-Pacific Transfection reagent and equipment.

METHODS

  • NON-VIRAL METHODS
  • VIRAL METHODS

On the basis of methods, the global Asia-Pacific Transfection reagent and equipment market is segmented into non-viral methods and viral methods.

TYPES OF MOLECULE

  • PLASMID DNA
  • DNA OLIGONUCLEOTIDES
  • SMALL INTERFERING RNA (SIRNA)
  • PROTEINS
  • RIBONUCLEOPROTEIN COMPLEXES (RNPS)
  • OTHERS

On the basis of types of molecule, the global Asia-Pacific Transfection reagent and equipment market is segmented into plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs) and others.

ORGANISM

  • BACTERIA
  • MAMMALIAN CELLS
  • FUNGI
  • PLANTS
  • VIRUS

On the basis of organism, the global Asia-Pacific Transfection reagent and equipment market is segmented into bacteria, mammalian cells, fungi, plants and virus.

APPLICATION

BY TYPE

  • IN VITRO APPLICATION
  • IN VIVO APPLICATION
  • BIOPRODUCTION
  • OTHERS

BY INDUSTRY

  • AGRICULTURE
  • SYNTHETIC BIOLOGY
  • OTHERS

On the basis of application, the global Asia-Pacific Transfection reagent and equipment market is segmented by type into in vitro application, in vivo application, bioproduction, others and by industry into agriculture, synthetic biology, others.

END USER

  • BIOPHARMA
  • CROS
  • CMOS/CDMOS
  • ACADEMIA
  • HOSPITALS
  • CLINICAL LABS
  • OTHERS

On the basis of end user, the global Asia-Pacific Transfection reagent and equipment market is segmented into biopharma, CROs, CMOs/ CDMOs, academia, hospitals, clinical labs and others.

DISTRIBUTION CHANNEL

  • DIRECT TENDER
  • RETAIL SALES
  • OTHERS

On the basis of distribution channel, the global Asia-Pacific Transfection Reagent and equipment market is segmented into direct tender, retail sales and others.

 

 Request Access for Free Sample Report: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-transfection-reagents-and-equipment-market

 

Segment Analysis:

By Products (Reagent & Kits and Instruments), Stage (Research, Preclinical, Clinical Phases, and Commercial), Type (Transient Asia-Pacific Transfection Reagent and Equipment, Stable Asia-Pacific Transfection Reagent, and Equipment), Methods (Non-viral Methods and Viral Methods), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), and Others), Organism (Mammalian Cells, Plants, Fungi, Virus, and Bacteria), Application (In Vitro Application, In Vivo Application, Bioproduction and Others), End User (Biopharma, CROs, (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others).

Countries Covered

               

U.S., Canada, Mexico, Germany, France, Italy, U.K., Spain, Switzerland, Russia, Netherlands, Belgium, Turkey, and Rest of Asia-Pacific, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Philippines, Indonesia, and Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt, and Rest of the Middle East and Africa.

Market Players Covered

Mirus Bio LLC., Promega Corporation, Polyplus Asia-Pacific Transfection, Bio-Rad Laboratories, Inc., Merck KGaA, Lonza, MaxCyte, Inc., Altogen Biosystems, SBS Genetech, FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation), Avanti Polar Lipids (A Subsidiary of  Croda International Plc),  PerkinElmer chemagen Technologie GmbH (A Subsidiary of  PerkinElmer Inc.), Cytiva, Geno Technology Inc., USA, R&D Systems, Inc., Takara Bio Inc., Thermofisher Scientific Inc., Roche Molecular Systems, Inc. (A Subsidiary of F. Hoffmann-La Roche Ltd), QIAGEN, OriGene Technologies, Inc., Applied Biological Materials Inc. (abm), Beckman Coulter, Inc. (A Subsidiary of Danaher), Amyris, Codexis, Autolus, SignaGen Laboratories, Impossible Foods Inc., Genlantis Inc., Ginkgo Bioworks, Verve Therapeutics, Inc., Conagen, Inc., Poseida Therapeutics, Inc., and Twist Bioscience, among others.

Access Full Report: https://www.databridgemarketresearch.com/reports/asia-pacific-transfection-reagents-and-equipment-market

Competitive Landscape and Polyvinylpyrrolidone (PVP) Market Share Analysis

The Asia-Pacific Transfection Reagent and Equipment Market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Asia-Pacific Transfection Reagent and Equipment Market.

 

Some of the major players covered in the report are Ashland, BALAJI AMINES, BASF SE, and Merck KGaA, among others.

Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-transfection-reagents-and-equipment-market

  Asia-Pacific Transfection Reagent and Equipment Market

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insights

Chapter Six:   Asia-Pacific Transfection Reagent and Equipment Market

 

Browse Treading Reports @

 

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email :  Sopan.gedam@databridgemarketresearch.com